409. Rapid Development of a Multiplexed PCR Prototype Method that Offers a Syndromic Diagnostic Option by Integrating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection with Twenty-One Other Common Respiratory Pathogens

BACKGROUND: The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for multiple PCR-based tests to aid in the diagnosis and containment of COVID-19. A vast majority of these tests detect only SARS-CoV-2 which causes symptoms similar to those caused by other respirato...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaulding, Usha, Antosch, Jeremiah, stone, Jessica, Robinson, Tanner, Halo, Kerrin, Kavetska, Iryna, Healy, Tyler, Taylor, Alex, Jones, Matthew, Todorov, Toma, Lu, Zhenmei, Cloud, Joann, Buccambuso, Maggie, Graham, Brad, Boone, Jeremy, Wood, Hillary, Rogatcheva, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777944/
http://dx.doi.org/10.1093/ofid/ofaa439.604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777944/
http://dx.doi.org/10.1093/ofid/ofaa439.604

Ejemplares similares